National Centre of Immuisation Research & Surveillance. Influenza vaccines for Australians | NCIRS Fact sheet: April 2016.
VanDamme, P., et al., Long-term persistenceof antibodies induced by vaccination and safety follow-up, with the firstcombined vaccine against hepatitis A and B in children and adults. J MedVirol, 2001. 65(1): p. 6-13.
Watson,B.M., et al., Safety and immunogenicityof a combined live attenuated measles, mumps, rubella, and varicella vaccine(MMR(II)V) in healthy children. J Infect Dis, 1996. 173(3): p. 731-4.
Bakker, M., et al., Immunogenicity, effectiveness and safety of combined hepatitis A and Bvaccine: a systematic literature review. Expert Rev Vaccines, 2016. 15(7): p. 829-51.
Gatchalian,S.R., et al., Immunogenicity,reactogenicity and safety of three-dose primary and booster vaccination withcombined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigencontent Haemophilus influenzae type b vaccine in Filipino children. HumVaccin, 2010. 6(8): 664-72.
Chippaux,J.P., et al., Immunogenicity, safety, andmemory of different schedules of Neisseria meningitidis A/C-diphtheria toxoidconjugate vaccine in infants in Niger. Vaccine, 2004. 22(25-26): 3303-11.
Treanor JJ. Influenza viruses, including avian influenza and swine influenza. In: Mandell GL, Bennett JE, Dolin R (editors). Mandell, Douglas, and Bennett's Principles and practice of infectious diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2010. p. 2265-88.
Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Influenza. In: Hamborsky J, Kroger A, Wolfe C (editors). Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington, DC: Public Health Foundation; 2015. p. 187-207.
American Academy of Pediatrics. Influenza. In: Kimberlin DW, Brady MT, Jackson MA, Long SS (editors). Red book: 2015 report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015. p. 476-93.
Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerging Infectious Diseases 2008;14:95-100.
Nelson E A, Ip M, Tam J S, et al. Burden of influenza infectionin hospitalised children below 6 months of age and above in Hong Kong from 2005 to 2011.Vaccine. 2014.
Neuzil K M, Hohlbein C, and Zhu Y. Illness amongschoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med. 2002, 156(10): 986-91.
Chiu S S, Chan K H, So L Y, et al. The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong Kong. Vaccine. 2012, 30(10): 1895-900.
Wang D, Zhang T, Wu J, et al. Socio-economic burden of influenza among children younger than 5 years in the outpatient setting in Suzhou, China. PLoS One. 2013, 8(8): e69035.
US CDC. Study Looks at Flu Vaccine Dosing in Children. Childrenwho got 2 doses as recommended had higher vaccine effectiveness. http://www.cdc.gov/flu/news/vaccine-dosing-children.htm
Fiore AE, Bridges CB, Katz JM, Cox NJ. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit PA (editors). Vaccines. 6th ed. Philadelphia, PA: Elsevier Saunders; 2012. p. 257-93.
Domachowske JB, Pankow-Culot H, Bautista M, et al. A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3–17 years.Journal of Infectious Diseases 2013;207:1878-87.
Kieninger D, Sheldon E, Lin WY, et al. Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years.BMC Infectious Diseases 2013;13:343.
Pépin S, Donazzolo Y, Jambrecina A, Salamand C, Saville M. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults. Vaccine 2013;31:5572-8. 40.
Greenberg DP, Robertson CA, Landolfi VA, et al. Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age. Pediatric Infectious Disease Journal 2014;33:630-6.
Greenhawt MJ, Li JT, Bernstein DI, et al. Administering influenza vaccine to egg allergic recipients: a focused practice parameter update. Annals of Allergy, Asthma and Immunology 2011;106:11-6.
Australasian Society of Clinical Immunology and Allergy (ASCIA). Guidelines for medical practitioners: Influenza vaccination of the egg-allergic individual. September 2010. Available from: www.allergy.org.au/health-professionals/papers/influenza-vaccination-of-the-egg-allergic-individual (Accessed February 2016).
Burwen DR, Ball R, Bryan WW, et al. Evaluation of Guillain-Barré syndrome among recipients of influenza vaccine in 2000 and 2001. American Journal of Preventive Medicine 2010;39:296-304.
Australian Technical Advisory Group on Immunisation (ATAGI). The Australian immunisation handbook. 10th ed (2015 update). Canberra: Australian Government Department of Health; 2015.
Australian Government Department of Health. Influenza (Flu). http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-influenza
Vaccination: Who Should Do It, Who Should Not and Who Should Take Precautions. http://www.cdc.gov/flu/protect/whoshouldvax.htm#egg-allergy
Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season. MMWR Recomm Rep 2018;67(No. RR-3):1–20.
Public Health England. Influenza vaccine effectiveness in adults and children in primary care in the United Kingdom: provisional end-of-season results 2017-18.